Evidence map›Paper›PMID 30187108›Full record

ArticlePsychopharmacology2018

Higher habitual dietary caffeine consumption is related to lower experimental pain sensitivity in a community-based sample.

Demario S Overstreet, Terence M Penn, Sarah T Cable, Edwin N Aroke, Burel R Goodin

Abstract read
In one paragraph

Article in Psychopharmacology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Effects of Caffeine and Caffeinated Beverages in Children, Adolescents and Young Adults: Short Review.International journal of environmental research and public health · 2021
    Review
  11. Review
  12. Review
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Demario S OverstreetDepartment of Psychology, University of Alabama at Birmingham, 1300 University Boulevard, Campbell Hall, Room 327E, Birmingham, AL, 35294, USA.
Terence M PennDepartment of Psychology, University of Alabama at Birmingham, 1300 University Boulevard, Campbell Hall, Room 327E, Birmingham, AL, 35294, USA.
Sarah T CableDepartment of Psychology, University of Alabama at Birmingham, 1300 University Boulevard, Campbell Hall, Room 327E, Birmingham, AL, 35294, USA.
Edwin N ArokeSchool of Nursing, Nurse Anesthesia Program, Department of Acute, Chronic, & Continuing Care, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Burel R GoodinDepartment of Psychology, University of Alabama at Birmingham, 1300 University Boulevard, Campbell Hall, Room 327E, Birmingham, AL, 35294, USA. bgoodin1@uab.edu.ORCID http://orcid.org/0000-0002-8159-1310
University of Alabama at Birmingham · USUniversity of Alabama at Birmingham Hospital · US

Funding

Research Education CoreP30AG031054 · NIA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI DURANT, RAEGAN WINSTON · 2007 to 2025
$11.6M
UAB Health Services Research (HSR) Training ProgramT32HS013852 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI LEVITAN, EMILY B, MUGAVERO, MICHAEL J · 2003 to 2024
$8.0M
Racial and Socioeconomic Differences in Chronic Low Back PainR01MD010441 · NIMHD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GOODIN, BUREL R., SORGE, ROBERT · 2017 to 2021
$2.6M
Agency for Healthcare Research and Quality T32HS013852AHRQ HHS T32 HS013852National Institute on Aging P30AG031054National Institute on Minority Health and Health Disparities R01MD010441NIA NIH HHS P30 AG031054NIMHD NIH HHS R01 MD010441
6 · The paper itself

Abstract

rationaleCaffeine is the most widely consumed psychoactive substance in the world. Caffeine administered acutely in a laboratory environment or as a medication adjuvant has known properties that help alleviate pain. However, much less is known about the potential impact of habitual dietary caffeine consumption on the experience of pain.

objectivesThe primary objective of this observational study was to determine whether caffeine consumed habitually as part of a daily diet was associated with experimental pain sensitivity using noxious stimuli in a non-clinical sample of 62 community-dwelling adults between 19 and 77 years old.

methodsStudy participants monitored their daily dietary caffeine consumption (e.g., coffee, tea, soda, energy drinks, and chocolate) across a period of seven consecutive days using a caffeine consumption diary. On the seventh day of caffeine consumption monitoring, participants presented to the laboratory to complete experimental pain sensitivity testing. Noxious thermal and mechanical stimuli were used to obtain threshold and tolerance for painful heat and pressure, respectively.

resultsData analysis revealed that greater self-reported daily caffeine consumption was significantly associated with higher heat pain threshold (β = .296, p = .038), higher heat pain tolerance (β = .242, p = .046), and higher pressure pain threshold (β = .277, p = .049) in multiple regression models adjusted for covariates.

conclusionsResults of this study completed with community-dwelling adults revealed that individuals who habitually consume greater amounts of caffeine as part of their daily diets demonstrate diminished sensitivity to painful stimuli in a laboratory setting.

Indexed as

AdultAgedCaffeineCarbonated BeveragesCoffeeEnergy DrinksFeeding BehaviorFemaleHumansIndependent LivingMaleMiddle AgedPainPain MeasurementPain ThresholdYoung AdultCaffeineCoffeeCaffeineDietary consumptionPain sensitivityThresholdTolerance

Identifiers

PMID30187108
PMCPMC6204079
OpenAlexW2892138902

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.